Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
9138studies shown
Showing 5,617-5,628 of 9,138
Other study type icon
CompletedNCT07434414

LRFN5 and OLFM4 in Bipolarity

This study is completed. It focuses on bipolarity and currently lists study information in Turkey.

In Elâzığ
BipolarityOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Elazığ Mental Health and Diseases Hospital
Condition
Bipolarity
Other study type icon
CompletedNCT07434388

LRFN5 and OLFM4 in Schizophrenia

This study is completed. It focuses on schizophrenia and currently lists study information in Turkey.

In Elâzığ
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Elazığ Mental Health and Diseases Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT04959032

Lumateperone for the Prevention of Relapse in people with Schizophrenia

This study is completed. It focuses on schizophrenia and currently lists study information in Bulgaria, Poland, Serbia, and the United States.

Multiple locations, including Little Rock
SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States, Bulgaria, Poland, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT03249376

Lumateperone Monotherapy for Depression in bipolarity Conducted Globally

This study is completed. It focuses on bipolarity and currently lists study information in Bulgaria, Colombia, Russian Federation, Serbia, Ukraine, and the United States.

Multiple locations, including Birmingham
Bipolarity, DepressionOtherFrom 18 Years to 75 Years
Countries
United States, Bulgaria, Colombia, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity, Depression
Mental Health | Clinical Trials | HopeStage Research